Market Research Report
Autoimmune Disease Diagnostics Market with COVID-19 Impact Analysis, By Test Type, By End User, and By Region - Size, Share, & Forecast from 2021-2027
|Autoimmune Disease Diagnostics Market with COVID-19 Impact Analysis, By Test Type, By End User, and By Region - Size, Share, & Forecast from 2021-2027|
Published: January 1, 2021
AnalystView Market Insights
Content info: 299 Pages
Delivery time: 2-3 business days
The global Autoimmune Disease Diagnostics market was valued at USD 4.63 billion in 2020, growing with 5.36% CAGR during the forecast period, 2021-2027.
Autoimmune disease diagnostics is very important owing to the rising number of autoimmune diseases cases. Consumables and assay kits are used to treat autoimmune diseases. Localized disease diagnostics type is projected to hold the largest market share in the global market.
The autoimmune disease diagnostics market is estimated to witness significant growth in the next few years. The growing prevalence of autoimmune diseases such as diabetes which occurs especially in newly born babies is expected to boost the market growth. In addition, technological advancement in product is projected to positively impact market growth. Several clinics are adopting new technology to conduct multiple tests with precise results.
Research & diagnostics institutes are taking initiatives under compliance with government authorities mainly due to growing prevalence of autoimmune diseases. According to National institute of health (NIH) autoimmune diseases are one of the key diseases that causes high mortality rate especially among women. Moreover, the increasing healthcare expenditure, and growing awareness about autoimmune diseases is expected to bolster the market growth.
The usage of conventional testing, and slow turnaround time are some of the key factors encouraging companies and laboratory testing to shift towards automation. Moreover, supportive government initiatives are projected to positively impact market growth. Various organization such as Co-operative Study Group disease Prevention, Autoimmunity Centers of Excellence are actively engaged in creating disease awareness. This is projected to fuel the market growth. According to survey done by American autoimmune disease association (AARDA) American patients ability to know about autoimmune disease is increased by around 10.0%.
North America market held the highest market share in 2019. The supportive government initiatives, and growing prevalence of disease are mainly contributing to market growth. According to AARDA data, around 50.0 million people in America have autoimmune disorder. Asia Pacific is projected to offer ample growth opportunities for market growth. The improving healthcare infrastructure, and growing awareness about autoimmune diseases is boosting the regional growth. Thus, Asia Pacific is anticipated to grow at the highest CAGR over the forecast period.
The Autoimmune Disease Diagnostics market is highly fragmented with the presence of international players. Key players in the market engages in R&D activities to develop new solutions. In addition, several companies indulges into strategic partnership with clinics & hospitals. For example, in 2017, Bio-Rad has partnered with VISA imaging to improve their automation capabilities.
Key features of the study:
This proposed research study on Autoimmune Disease Diagnostics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Autoimmune Disease Diagnostics market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Autoimmune Disease Diagnostics market
Impact of COVID-19 on Autoimmune Disease Diagnostics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Autoimmune Disease Diagnostics market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Autoimmune Disease Diagnostics market, we have also included competitive landscape and key innovator analysis for the Autoimmune Disease Diagnostics market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and end-user's attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Autoimmune Disease Diagnostics market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the Autoimmune Disease Diagnostics market on global as well as regional level.
The global Autoimmune Disease Diagnostics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET KEY PLAYERS
Thermo Fisher Scientific
HTG Molecular Diagnostics
Seramun Diagnostica GmbH
Cambridge Life Sciences Limited
GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TYPES
Localized autoimmune disease diagnostics
Idiopathic thrombocytopenic purpura
Type 1 diabetes
Systemic autoimmune disease diagnostics
Systemic lupus erythematosus (SLE)
GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT
Consumables & Assay Kits
GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE
Antinuclear Antibody Tests
Complete Blood Count (CBC)
C - reactive protein (CRP)
GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER
GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
The Middle East and Africa
United Arab Emirates
Rest of MEA
List of Tables
List of Figures